Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Olga, Blau"'
Autor:
Adriane Halik, Marlon Tilgner, Patricia Silva, Natalia Estrada, Robert Altwasser, Ekaterina Jahn, Michael Heuser, Hsin-An Hou, Marta Pratcorona, Robert K. Hills, Klaus H. Metzeler, Laurene Fenwarth, Anna Dolnik, Christine Terre, Klara Kopp, Olga Blau, Martin Szyska, Friederike Christen, Jan Krönke, Loïc Vasseur, Bob Löwenberg, Jordi Esteve, Peter J. M. Valk, Matthieu Duchmann, Wen-Chien Chou, David C. Linch, Hartmut Döhner, Rosemary E. Gale, Konstanze Döhner, Lars Bullinger, Kenichi Yoshida, Frederik Damm
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-18 (2024)
Abstract Background Deletions and partial losses of chromosome 7 (chr7) are frequent in acute myeloid leukemia (AML) and are linked to dismal outcome. However, the genomic landscape and prognostic impact of concomitant genetic aberrations remain inco
Externí odkaz:
https://doaj.org/article/c4bde76aa3284c6f887bca011315517d
Autor:
Malgorzata Lienhart, Yichen Liu, Ekaterina Slonova, Anna Dolnik, Igor Wolfgang Blau, Axel Nogai, Lars Bullinger, Olga Blau
Publikováno v:
HemaSphere, Vol 7, p e950158a (2023)
Externí odkaz:
https://doaj.org/article/1423718799834ca3bf4cd92b2a57c1c1
Autor:
Hao Dai, Sivaramakrishna P. Rachakonda, Olaf Penack, Igor W. Blau, Olga Blau, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, Rajiv Kumar, Thomas Luft
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-12 (2021)
Abstract Chronic graft-versus-host disease (cGVHD) is a major cause of mortality and morbidity after allogeneic stem cell transplantation (alloSCT). The individual risk of severe cGVHD remains difficult to predict and may involve CXCR3 ligands. This
Externí odkaz:
https://doaj.org/article/971e0d0bb95d481495b6e90192e86eeb
Publikováno v:
Case Reports in Hematology, Vol 2022 (2022)
The majority of patients with acute myeloid leukemia (AML) with the NPM1 mutation achieve remission with intensive chemotherapy. However, many patients subsequently relapse, which occurs frequently within the first 2–3 years after therapy, while la
Externí odkaz:
https://doaj.org/article/8a7f78f9f2b04f0ebb7137d74d67ae70
Autor:
Nadja Stobutzki, Stephan Schlickeiser, Mathias Streitz, Katarina Stanko, Kim-Long Truong, Levent Akyuez, Katrin Vogt, Christine Appelt, Andreas Pascher, Olga Blau, Undine A. Gerlach, Birgit Sawitzki
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
The intestine mediates a delicate balance between tolerogenic and inflammatory immune responses. The continuous pathogen encounter might also augment immune cell responses contributing to complications observed upon intestinal transplantation (ITx).
Externí odkaz:
https://doaj.org/article/2fdde8e4db2e4ff9a12b1920757b368b
Autor:
Michael Heuser, Nouraldin Damrah, Razif Gabdoulline, Courteney K. Lai, Eric Sträng, Mustafa Salim, Gudrun Göhring, Yvonne L. Behrens, Ekaterina Jahn, Martin Wichmann, Jens F. Schrezenmeier, Yasmine Alwie, Joerg Westermann, Frederick Damm, Brigitte Schlegelberger, Frank G. Rücker, Hartmut Döhner, Arnold Ganser, Felicitas R. Thol, Olga Blau, Konstanze Döhner, Lars Bullinger, Anna Dolnik
Publikováno v:
Blood. 140:6070-6072
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3317b3d33bc6fffd5c6462eb3955c3e7
https://doi.org/10.1182/blood-2022-163035
https://doi.org/10.1182/blood-2022-163035
Publikováno v:
European Medical Journal Oncology, Vol 4, Iss 1, Pp 122-129 (2016)
Myelodysplastic syndrome (MDS) is a heterogeneous group of myeloid disorders. Allogeneic stem cell transplantation (alloSCT) is the therapeutic approach with a known curative potential for patients with MDS, which allows long-term disease control to
Externí odkaz:
https://doaj.org/article/2b172d94618b49f8838c053d9ae2b6f3
Autor:
Symbat Saliyeva, Riza Boranbayeva, Natalya Konoplya, Minira Bulegenova, Olga Blau, Vyacheslav Belousov, Joanna Granica, Dina Mukushkina, Gulmira Altynbayeva
Publikováno v:
Journal of pediatric hematology/oncology.
Germ cell tumors (GCTs) may occur from the neonatal period to late adulthood, characterized by extensive clinical and pathologic heterogeneity. MicroRNAs are a family of small noncoding RNAs that regulate a wide array of biological processes includin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::906984e570fbcc57456597c7cb219780
https://pubmed.ncbi.nlm.nih.gov/35700382
https://pubmed.ncbi.nlm.nih.gov/35700382
Publikováno v:
Biomarker Insights, Vol 10s3 (2015)
Externí odkaz:
https://doaj.org/article/3087aad75473442987e512c0c8057bef
Autor:
Esther Schuler, Michael Koldehoff, Florian Kuchenbauer, Armin Gerbitz, David Michonneau, Maximilian Christopeit, Tomasz Zemojtel, Gérard Socié, Guido Kobbe, Joel Galan-Sousa, Eva Wagner, Felicitas Thol, Adriane Halik, Raphael Hablesreiter, Mareike Frick, Johannes Schetelig, Christian Thiede, Friederike Christen, Olga Blau, Kaja Hoyer, Frederik Damm, Kenichi Yoshida, Michael Heuser, Nicolaus Kroeger, Martin Bornhäuser, Francis Ayuk, Igor Wolfgang Blau, Willy Chan, Hubert Schrezenmeier, Daniel Noerenberg, Emmanuelle Clappier, Michael Stadler, Bernd M. Spriewald, Lars Bullinger, Seishi Ogawa, Christopher Maximilian Arends, Verena Wais, M Wiesneth
Publikováno v:
Journal of Clinical Oncology. 37:375-385
Purpose Clonal hematopoiesis of indeterminate potential (CHIP) occurs in the blood of approximately 20% of older persons. CHIP is linked to an increased risk of hematologic malignancies and of all-cause mortality; thus, the eligibility of stem-cell d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51e6e28d1c238a6cae17430ad5b53e49
https://doi.org/10.1200/jco.2018.79.2184
https://doi.org/10.1200/jco.2018.79.2184